UnknownPhase 4

Safety and Efficacy Study of Artificial Cornea

India20 participantsStarted 2010-08

Plain-language summary

The purpose of this study is to evaluate the stability of artificial cornea manufactured by Aurolab and to assess its visual outcomes.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age more than 20 years * Willing to participate and review on schedule * Multiple failed grafts with poor prognosis for regrafting * Adequate tear film and lid function * Projection of light in all quadrants * Bilateral blind Exclusion Criteria: * Reasonable chance of success with keratoplasty * Autoimmune disease such as Stevens Johnson Syndrome, Pemphigoid * End stage glaucoma * Retinal detachment

What they're measuring

Visual Acuity

Timeframe: 1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month

Trial details

NCT IDNCT01018888

SponsorAurolab

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-06

Contact for this trial

Mr.Karthikumar S, M.Pharm

0452-3096100 crd@aurolab.com

View on ClinicalTrials.gov More Corneal Transplantation trials